Commit To Purchase Clovis Oncology At $35, Earn 12.3% Using Options
February 23, 2017 at 11:53 AM EST
Investors considering a purchase of Clovis Oncology Inc (CLVS) shares, but tentative about paying the going market price of $58.51/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2019 put at the $35 strike, which has a bid at the time of this writing of $4.30..